Bio-Techne (TECH) Net Cash Flow (2009 - 2026)
Bio-Techne (TECH) posted quarterly Net Cash Flow of $38.1 million for Q1 2026, up 206.51% year-over-year from $12.4 million in Q1 2025, and up 38.63% quarter-over-quarter from $27.5 million in Q4 2025.
Analysis
Bio-Techne (TECH) Net Cash Flow (2009 - 2026) Analysis & Trends
Bio-Techne's Net Cash Flow history runs 18 years deep, the most recent figure standing at $38.1 million for Q1 2026.
- In Q1 2026, Net Cash Flow rose 206.51% year-over-year to $38.1 million; the TTM figure through Mar 2026 stood at $57.8 million (up 1967.26% YoY), while the FY2025 annual figure was -$1.5 million, up 94.21% from the prior year.
- Net Cash Flow for Q1 2026 stood at $38.1 million, up from $27.5 million in the prior quarter.
- The five-year high for Net Cash Flow was $54.4 million in Q2 2023, with the low at -$46.9 million in Q1 2022.
- The 5-year median for Net Cash Flow is $4.6 million (2022), against an average of $264000.0.
- The sharpest annual moves came in 2023 and 2025: Net Cash Flow tumbled 606.1% in 2023, then surged 708.09% in 2025.
- Bio-Techne's Net Cash Flow stood at -$7.9 million in 2022, then slumped by 177.2% to -$22.0 million in 2023, then soared by 79.4% to -$4.5 million in 2024, then soared by 708.09% to $27.5 million in 2025, then jumped by 38.63% to $38.1 million in 2026.
- Business Quant data shows TECH's Net Cash Flow at $38.1 million in Q1 2026, $27.5 million in Q4 2025, and -$16.0 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -183.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 407.41 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -496,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn | 55.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.15 Mn |
| Mar 31, 2026 | 38.13 Mn |
| Dec 31, 2025 | 27.50 Mn |
| Sep 30, 2025 | -16.01 Mn |
| Jun 30, 2025 | 8.16 Mn |
| Mar 31, 2025 | -35.80 Mn |
| Dec 31, 2024 | -4.52 Mn |
| Sep 30, 2024 | 30.63 Mn |
| Jun 30, 2024 | 6.59 Mn |
| Mar 31, 2024 | 12.13 Mn |
| Dec 31, 2023 | -21.95 Mn |
| Sep 30, 2023 | -23.22 Mn |
| Jun 30, 2023 | 54.42 Mn |
| Mar 31, 2023 | -39.72 Mn |
| Dec 31, 2022 | -7.92 Mn |
| Sep 30, 2022 | 4.59 Mn |
| Jun 30, 2022 | 18.42 Mn |
| Mar 31, 2022 | -46.93 Mn |
| Dec 31, 2021 | 12.45 Mn |
| Sep 30, 2021 | 1.63 Mn |